HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms: Difference between revisions
Bailey.Glen (talk | contribs) Created page with "==Primary Author(s)*== Daniel Butler, MD Daynna J. Wolff, PhD __TOC__ ==Graphical Data Links== '''AML Table''' - A comprehensive list of CNAs and CN-LOH detectable by CMA..." |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 31: | Line 31: | ||
==WHO Classification Pages (Includes Links to Content)== | ==WHO Classification Pages (Includes Links to Content)== | ||
*[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | *[[HAEM4:Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | ||
- [[Acute | - [[HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with KMT2A rearrangement|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion|AML with t(6;9)(p23;q34.1); DEK-NUP214]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with MECOM rearrangement|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|AML with BCR-ABL1]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with NPM1 mutation|AML with Mutated NPM1]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with CEBPA mutation|AML with Biallelic Mutations of CEBPA]] | ||
- [[Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] | - [[HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] | ||
*[[Acute | *[[HAEM5:Acute myeloid leukaemia, myelodysplasia-related|AML with Myelodysplasia-Related Changes]] | ||
*[[ | *[[HAEM5:Myeloid neoplasm post cytotoxic therapy]] | ||
*[[Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] | *[[HAEM4:Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with minimal differentiation|AML with Minimal Differentiation]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia without maturation|AML without Maturation]] | ||
- [[Acute | - [[HAEM5:Acute myeloid leukaemia with maturation|AML with Maturation]] | ||
- [[Acute | - [[HAEM5:Acute myelomonocytic leukaemia]] | ||
- [[Acute | - [[HAEM5:Acute monocytic leukaemia]] | ||
- [[ | - [[HAEM5:Acute erythroid leukaemia]] | ||
- [[Acute | - [[HAEM5:Acute megakaryoblastic leukaemia]] | ||
- [[Acute | - [[HAEM5:Acute basophilic leukaemia]] | ||
- [[Acute Panmyelosis with Myelofibrosis]] | - [[HAEM4:Acute Panmyelosis with Myelofibrosis]] | ||
*[[Myeloid | *[[HAEM5:Myeloid sarcoma]] | ||
*[[Myeloid Proliferations Associated with Down Syndrome]] | *[[HAEM4:Myeloid Proliferations Associated with Down Syndrome]] | ||
- [[ | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] | ||
- [[Myeloid | - [[HAEM5:Myeloid proliferations associated with Down syndrome]] | ||
*[[Blastic | *[[HAEM5:Blastic plasmacytoid dendritic cell neoplasm]] | ||
*[[Acute Leukemias of Ambiguous Lineage]] | *[[HAEM4:Acute Leukemias of Ambiguous Lineage]] | ||
- [[Acute | - [[HAEM5:Acute undifferentiated leukaemia]] | ||
- [[Mixed | - [[HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] | ||
- [[Mixed | - [[HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement]] | ||
- [[Mixed | - [[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid]] | ||
- [[Mixed | - [[HAEM5:Mixed-phenotype acute leukaemia, T/myeloid]] | ||
- [[Mixed- | - [[HAEM5:Mixed-phenotype acute leukaemia, rare types]] | ||
- [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | - [[HAEM4:Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | ||
*[[Myeloid Neoplasms with Germline Predisposition]] | *[[Myeloid Neoplasms with Germline Predisposition]] | ||
- [[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | - [[HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | ||
- [[Myeloid Neoplasms with Germline DDX41 Mutation]] | - [[HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation]] | ||
- [[Myeloid Neoplasms with Germline RUNX1 Mutation]] | - [[HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation]] | ||
- [[Myeloid Neoplasms with Germline ANKRD26 Mutation]] | - [[HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation]] | ||
- [[Myeloid Neoplasms with Germline ETV6 Mutation]] | - [[HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation]] | ||
- [[Myeloid Neoplasms with Germline GATA2 Mutation]] | - [[HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation]] | ||
==Other Related Pages (Includes Links to Content)== | ==Other Related Pages (Includes Links to Content)== | ||
*[[ | *[[HAEM5:Myeloid/lymphoid neoplasm with FLT3 rearrangement|AML with Mutated FLT3]] | ||
*[[Acute Myeloid Leukemia (AML) with NUP214-ABL1|AML with NUP214-ABL1]] | *[[HAEM4:Acute Myeloid Leukemia (AML) with NUP214-ABL1|AML with NUP214-ABL1]] | ||
*[[Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6|AML with t(4;12)(q12;p13); CHIC2-ETV6]] | *[[HAEM4:Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6|AML with t(4;12)(q12;p13); CHIC2-ETV6]] | ||
==Additional Information== | ==Additional Information== | ||